Canopy Growth logo

CGC - Canopy Growth News Story

$17.93 1.3  7.8%

Last Trade - 10/08/20

Sector
Healthcare
Size
Large Cap
Market Cap £5.09bn
Enterprise Value £4.41bn
Revenue £228.5m
Position in Universe 974th / 6400

BUZZ-Canopy Growth: Drops on wider Q1 loss, impairment charges

Fri 29th May, 2020 1:01pm
** U.S.-listed shares of pot company  CGC.N   WEED.TO  fall
17% to $17.95 premarket 
    ** Company reports Q1 net loss attributable of C$1.30
billion ($946.62 mln), vs loss of C$379.5 mln a year ago
 urn:newsml:reuters.com:*:nASA00S04
    ** Canopy records non-cash impairment and
restructuring-related charges of C$743 mln in quarter
    ** Also withdraws its previous outlook for positive adjusted
EBITDA and net income in fiscal 2021
    ** U.S- listed shares of other pot firms Aurora Cannabis
 ACB.N , Aphria Inc  APHA.N , Hexo Corp  HEXO.N , Cronos Group
 CRON.O  and Tilray  TLRY.O  down between 1.5% and 4.7% 
    ** Canopy Growth's NYSE-listed shares up ~3% YTD, while
TSX-listed shares up ~12%


($1 = 1.3733 Canadian dollars)

 (Reporting by Shradha Singh in Bengaluru)
 ((Shradha.Singh@thomsonreuters.com; within U.S. +1 646 223 8780
Ext: 2804, outside U.S. +91 80 6182 2630;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.